Novome Biotechnologies Revenue and Competitors

Location

$38M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Novome Biotechnologies's estimated annual revenue is currently $930k per year.(i)
  • Novome Biotechnologies's estimated revenue per employee is $77,500
  • Novome Biotechnologies's total funding is $38M.

Employee Data

  • Novome Biotechnologies has 12 Employees.(i)
  • Novome Biotechnologies grew their employee count by -76% last year.

Novome Biotechnologies's People

NameTitleEmail/Phone
1
Co-Founder & CSOReveal Email/Phone
2
Co-FounderReveal Email/Phone
3
Co-FounderReveal Email/Phone
4
CEOReveal Email/Phone
5
VP ResearchReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Novome Biotechnologies?

Novome Biotechnologies is engineering bacteria from the human gut to treat diseases. Based on pioneering technology developed at Stanford University, we bring together experts in the fields of synthetic biology and the microbiome to build novel cell-based therapies.

keywords:N/A

$38M

Total Funding

12

Number of Employees

$930k

Revenue (est)

-76%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Novome Biotechnologies News

2020-01-09 - Novome Biotechnologies Secures $33M in Series A Financing

Novome Biotechnologies, Inc., a South San Francisco, Calif.-based biotechnology company engineering living medicines for chronic diseases, secured $33m in Series A financing. The round was led by DCVC Bio with participation from seed investor 5AM Ventures, Alta Partners, Alexandria Venture Inve ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.9M12-8%N/A
#2
$1.8M120%N/A
#3
$1M13-78%$187.1M
#4
$1.7M13-13%N/A
#5
$1.8M15-6%N/A